Henrik Verder

2.2k total citations
36 papers, 1.6k citations indexed

About

Henrik Verder is a scholar working on Pulmonary and Respiratory Medicine, Endocrine and Autonomic Systems and Surgery. According to data from OpenAlex, Henrik Verder has authored 36 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 12 papers in Endocrine and Autonomic Systems and 11 papers in Surgery. Recurrent topics in Henrik Verder's work include Neonatal Respiratory Health Research (21 papers), Neuroscience of respiration and sleep (12 papers) and Respiratory Support and Mechanisms (10 papers). Henrik Verder is often cited by papers focused on Neonatal Respiratory Health Research (21 papers), Neuroscience of respiration and sleep (12 papers) and Respiratory Support and Mechanisms (10 papers). Henrik Verder collaborates with scholars based in Denmark, Sweden and United Kingdom. Henrik Verder's co-authors include Finn Ebbesen, Gorm Greisen, Per Albertsen, Bengt Robertson, Thorkild Jacobsen, Kaare Engell Lundstrøm, Lone Agertoft, J Reinholdt, Aksel Bertelsen and E. Nathan and has published in prestigious journals such as New England Journal of Medicine, PEDIATRICS and Scientific Reports.

In The Last Decade

Henrik Verder

36 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henrik Verder Denmark 19 1.3k 673 589 310 101 36 1.6k
Ola Hjalmarson Sweden 22 835 0.6× 286 0.4× 445 0.8× 205 0.7× 195 1.9× 49 1.2k
Chiara Poggi Italy 25 686 0.5× 161 0.2× 231 0.4× 519 1.7× 95 0.9× 51 1.3k
Jonathan M. Klein United States 20 778 0.6× 212 0.3× 396 0.7× 284 0.9× 112 1.1× 55 1.0k
Raquel Escrig Spain 13 814 0.6× 395 0.6× 194 0.3× 358 1.2× 81 0.8× 19 1.0k
Gary R. Gutcher United States 16 428 0.3× 106 0.2× 133 0.2× 361 1.2× 78 0.8× 33 715
Haruo Maeta United States 9 832 0.6× 498 0.7× 316 0.5× 125 0.4× 30 0.3× 25 951
Laurent Storme France 18 601 0.4× 83 0.1× 598 1.0× 323 1.0× 55 0.5× 60 1.1k
E. A. Egan United States 16 880 0.7× 283 0.4× 277 0.5× 88 0.3× 79 0.8× 23 1.1k
Zbyněk Straňák Czechia 17 711 0.5× 234 0.3× 338 0.6× 288 0.9× 117 1.2× 61 1.2k
Liping Sun China 13 389 0.3× 92 0.1× 171 0.3× 365 1.2× 96 1.0× 56 883

Countries citing papers authored by Henrik Verder

Since Specialization
Citations

This map shows the geographic impact of Henrik Verder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Verder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Verder more than expected).

Fields of papers citing papers by Henrik Verder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henrik Verder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Verder. The network helps show where Henrik Verder may publish in the future.

Co-authorship network of co-authors of Henrik Verder

This figure shows the co-authorship network connecting the top 25 collaborators of Henrik Verder. A scholar is included among the top collaborators of Henrik Verder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henrik Verder. Henrik Verder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ronit, Andreas, Henning B. Nielsen, Thomas Benfield, et al.. (2022). Reduced levels of pulmonary surfactant in COVID-19 ARDS. Scientific Reports. 12(1). 4040–4040. 26 indexed citations
2.
Wiese, Lothar, et al.. (2020). Assessment of pulmonary surfactant in COVID-19 patients. Critical Care. 24(1). 552–552. 28 indexed citations
3.
Verder, Henrik, Christian Heiring, Rangasamy Ramanathan, et al.. (2020). Bronchopulmonary dysplasia predicted at birth by artificial intelligence. Acta Paediatrica. 110(2). 503–509. 22 indexed citations
4.
Heiring, Christian, Henrik Verder, Torben E. Jessen, et al.. (2019). Predicting respiratory distress syndrome at birth using a fast test based on spectroscopy of gastric aspirates: 2. Clinical part. Acta Paediatrica. 109(2). 285–290. 20 indexed citations
5.
Jessen, Torben E., Agnar Höskuldsson, Poul Jannik Bjerrum, et al.. (2014). Simultaneous determination of glucose, triglycerides, urea, cholesterol, albumin and total protein in human plasma by Fourier transform infrared spectroscopy: Direct clinical biochemistry without reagents. Clinical Biochemistry. 47(13-14). 1306–1312. 37 indexed citations
6.
Verder, Henrik, Finn Ebbesen, Jesper Fenger‐Grøn, et al.. (2013). Early Surfactant Guided by Lamellar Body Counts on Gastric Aspirate in Very Preterm Infants. Neonatology. 104(2). 116–122. 20 indexed citations
7.
Verder, Henrik, Finn Ebbesen, John T. Brandt, et al.. (2010). Lamellar body counts on gastric aspirates for prediction of respiratory distress syndrome. Acta Paediatrica. 100(2). 175–180. 19 indexed citations
8.
Verder, Henrik, Kajsa Bohlin, J Kamper, Robert Lindwall, & Baldvin Jónsson. (2009). Nasal CPAP and surfactant for treatment of respiratory distress syndrome and prevention of bronchopulmonary dysplasia. Acta Paediatrica. 98(9). 1400–1408. 60 indexed citations
9.
Verder, Henrik. (2007). Nasal CPAP has become an indispensable part of the primary treatment of newborns with respiratory distress syndrome. Acta Paediatrica. 96(4). 482–484. 45 indexed citations
10.
Ebbesen, Finn, Charlotte Brix Andersson, Henrik Verder, et al.. (2005). Extreme hyperbilirubinaemia in term and near‐term infants in Denmark. Acta Paediatrica. 94(1). 59–64. 76 indexed citations
11.
Verder, Henrik, Finn Ebbesen, Bengt Robertson, et al.. (2003). Prediction of respiratory distress syndrome by the microbubble stability test on gastric aspirates in newborns of less than 32 weeks’gestation. Acta Paediatrica. 92(6). 728–733. 23 indexed citations
12.
Verder, Henrik, et al.. (2000). Soluble intercellular adhesion molecule and C-reactive protein as early markers of infection in newborns. Journal of Perinatal Medicine. 28(2). 97–103. 23 indexed citations
13.
Kroner, John, et al.. (1995). [Neonatal mortality, morbidity and late sequelae in infants with birth weight under 1.501 gr or gestational age under 31 weeks, primarily admitted to a central hospital].. PubMed. 157(41). 5707–11. 4 indexed citations
14.
Verder, Henrik, Bengt Robertson, Gorm Greisen, et al.. (1994). Surfactant Therapy and Nasal Continuous Positive Airway Pressure for Newborns with Respiratory Distress Syndrome. New England Journal of Medicine. 331(16). 1051–1055. 329 indexed citations
15.
Olsen, Jørgen H., et al.. (1994). Vitamin K regimens and incidence of childhood cancer in Denmark. BMJ. 308(6933). 895–896. 37 indexed citations
16.
Verder, Henrik, et al.. (1991). Anal Tonometry in the Neonatal Period for the Diagnosis of Hirschsprung's Disease. Acta Paediatrica. 80(1). 45–50. 5 indexed citations
17.
Verder, Henrik. (1979). Factors predisposing to respiratory distress syndrome.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 26(3). 130–2. 1 indexed citations
18.
Verder, Henrik, et al.. (1978). Lecithin-spingomyelin ratio in eight cases of premature rupture of the membranes.. PubMed. 25(5). 218–20. 2 indexed citations
19.
Verder, Henrik & Jens Clausen. (1974). Assay of phospholipids in the amniotic fluid. Clinica Chimica Acta. 51(3). 257–269. 9 indexed citations
20.
Verder, Henrik & Jens Clausen. (1974). Idiopathic respiratory distress syndrome and the phospholipids in the amniotic fluid. Clinica Chimica Acta. 51(3). 271–275. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ola Hjalmarson Breakdown of academic impact, for papers by Chiara Poggi Breakdown of academic impact, for papers by Jonathan M. Klein Breakdown of academic impact, for papers by Raquel Escrig Breakdown of academic impact, for papers by Gary R. Gutcher Breakdown of academic impact, for papers by Haruo Maeta Breakdown of academic impact, for papers by Laurent Storme Breakdown of academic impact, for papers by E. A. Egan Breakdown of academic impact, for papers by Zbyněk Straňák Breakdown of academic impact, for papers by Liping Sun
Rankless by CCL
2026